LakeShore Biopharma Co., Ltd LSB
0.63 USD 0.00 (+0.00%)
At closeSep 19, 2025, 4:00 PM EDT
0.627 Day range 0.7899
1.88 52-week range 11.20
- YTD
- 0.00%
- 1 year
- 0.00%
Revenue & Expenses
Latest period ending Mar 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 |
|---|---|---|---|---|---|
| 614.96M | 573.42M | 687.20M | 502.95M | 257.02M | |
| 507.19M | 455.73M | 533.84M | 385.88M | 197.36M | |
| -86.29M | -445.83M | -139.38M | -118.96M | -125.85M | |
| -99.98M | -433.46M | -283.47M | -236.67M | -208.44M | |
| -5.22 | -40.54 | -23.55 | -17.10 | -31.00 |
Balance sheet
| Fiscal year | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 |
|---|---|---|---|---|---|
| 107.48M | 246.55M | 370.37M | 271.07M | 390.46M | |
| 1.37B | 1.51B | 1.72B | 1.44B | 1.17B | |
| 867.91M | 927.82M | 991.30M | 770.50M | 390.58M | |
| 414.40M | 424.46M | 498.63M | 380.59M | 18.44M | |
| 499.75M | 585.21M | 728.45M | -698.97M | -508.86M |
Cash flow
| Fiscal year | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 |
|---|---|---|---|---|---|
| -120.98M | -295.23M | -182.47M | -173.55M | -246.61M | |
| -17.01M | -44.25M | -56.98M | -298.92M | -104.24M | |
| -3.58M | 205.26M | 317.45M | 364.56M | 739.26M | |
| -11.86M | -44.25M | -52.69M | -295.31M | -104.24M | |
| -139.07M | -123.82M | 99.30M | -119.39M | 388.41M |